[1] |
FU X, LIU G, HALIM A, et al. Mesenchymal stem cell migration and tissue repair[J]. Cells, 2019, 8(8): 784. DOI: 10.3390/cells8080784.
|
[2] |
ARAÚJO AB, SALTON GD, FURLAN JM, et al. Comparison of human mesenchymal stromal cells from four neonatal tissues: amniotic membrane, chorionic membrane, placental decidua and umbilical cord[J]. Cytotherapy, 2017, 19(5): 577-585. DOI: 10.1016/j.jcyt.2017.03.001.
|
[3] |
VALIULIENĖ G, ZENTELYTĖ A, BERŽANSKYTĖ E, et al. Metabolic profile and neurogenic potential of human amniotic fluid stem cells from normal vs. fetus-affected gestations[J]. Front Cell Dev Biol, 2021, 9: 700634. DOI: 10.3389/fcell.2021.700634.
|
[4] |
FRIEDENSTEIN AJ, CHAILAKHYAN RK, LATSINIK NV, et al. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. cloning in vitro and retransplantation in vivo[J]. Transplantation, 1974, 17(4): 331-340. DOI: 10.1097/00007890-197404000-00001.
|
[5] |
薛玲玲, 陈锦阳, 庄盼, 等. 人羊膜上皮细胞和人羊膜间充质干细胞的研究进展[J/CD]. 中华细胞与干细胞杂志(电子版), 2021, 11(3): 184-188. DOI: 10.3877/cma.j.issn.2095-1221.2021.03.008.XUE LL, CHEN JY, ZHUANG P, et al. Updated progress of human amniotic epithelial cells and human amniotic mesenchymal stem cells[J/CD]. Chin J Cell Stem Cell, 2021, 11(3): 184-188. DOI: 10.3877/cma.j.issn.2095-1221.2021.03.008.
|
[6] |
MUCIENTES A, HERRANZ E, MORO E, et al. Influence of mesenchymal stem cell sources on their regenerative capacities on different surfaces[J]. Cells, 2021, 10(2): 481. DOI: 10.3390/cells10020481.
|
[7] |
华天桢, 马雨诗, 房贺. 干细胞在肝损伤治疗中的应用与机制[J]. 实用医学杂志, 2021, 37(7): 839-844. DOI: 10.3969/j.issn.1006-5725.2021.07.003.HUA TZ, MA YS, FANG H. The mechanism and progress of stem cells in the treatment of hepatocyte injury[J]. J Pract Med, 2021, 37(7): 839-844. DOI: 10.3969/j.issn.1006-5725.2021.07.003.
|
[8] |
SHEN C, YANG C, XU S, et al. Comparison of osteogenic differentiation capacity in mesenchymal stem cells derived from human amniotic membrane (AM), umbilical cord (UC), chorionic membrane (CM), and decidua (DC)[J]. Cell Biosci, 2019, 9: 17. DOI: 10.1186/s13578-019-0281-3.
|
[9] |
MATHEW SA, NAIK C, CAHILL PA, et al. Placental mesenchymal stromal cells as an alternative tool for therapeutic angiogenesis[J]. Cell Mol Life Sci, 2020, 77(2): 253-265. DOI: 10.1007/s00018-019-03268-1.
|
[10] |
CALCAT-I-CERVERA S, SANZ-NOGUÉS C, O'BRIEN T. When origin matters: properties of mesenchymal stromal cells from different sources for clinical translation in kidney disease[J]. Front Med (Lausanne), 2021, 8: 728496. DOI: 10.3389/fmed.2021.728496.
|
[11] |
FU YX, JI J, SHAN F, et al. Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunities[J]. Stem Cell Res Ther, 2021, 12(1): 161. DOI: 10.1186/s13287-021-02212-0.
|
[12] |
KUNISAKI SM. Amniotic fluid stem cells for the treatment of surgical disorders in the fetus and neonate[J]. Stem Cells Transl Med, 2018, 7(11): 767-773. DOI: 10.1002/sctm.18-0018.
|
[13] |
DE COPPI P, BARTSCH G JR, SIDDIQUI MM, et al. Isolation of amniotic stem cell lines with potential for therapy[J]. Nat Biotechnol, 2007, 25(1): 100-106. DOI: 10.1038/nbt1274.
|
[14] |
ALESSIO N, PIPINO C, MANDATORI D, et al. Mesenchymal stromal cells from amniotic fluid are less prone to senescence compared to those obtained from bone marrow: an in vitro study[J]. J Cell Physiol, 2018, 233(11): 8996-9006. DOI: 10.1002/jcp.26845.
|
[15] |
PRATHEESH MD, DUBEY PK, GADE NE, et al. Comparative study on characterization and wound healing potential of goat (Capra hircus) mesenchymal stem cells derived from fetal origin amniotic fluid and adult bone marrow[J]. Res Vet Sci, 2017, 112: 81-88. DOI: 10.1016/j.rvsc.2016.12.009.
|
[16] |
PARK HJ, CHO HY, CHA DH. The amniotic fluid cell-free transcriptome provides novel information about fetal development and placental cellular dynamics[J]. Int J Mol Sci, 2021, 22(5): 2612. DOI: 10.3390/ijms22052612.
|
[17] |
LOUKOGEORGAKIS SP, DE COPPI P. Stem cells from amniotic fluid--potential for regenerative medicine[J]. Best Pract Res Clin Obstet Gynaecol, 2016, 31: 45-57. DOI: 10.1016/j.bpobgyn.2015.08.009.
|
[18] |
AZARGOON A, NEGAHDARI B. Lung regeneration using amniotic fluid mesenchymal stem cells[J]. Artif Cells Nanomed Biotechnol, 2018, 46(3): 447-451. DOI: 10.1080/21691401.2017.1337023.
|
[19] |
PARK J, JUN EK, SON D, et al. Overexpression of Nanog in amniotic fluid-derived mesenchymal stem cells accelerates dermal papilla cell activity and promotes hair follicle regeneration[J]. Exp Mol Med, 2019, 51(7): 1-15. DOI: 10.1038/s12276-019-0266-7.
|
[20] |
TAKOV K, HE Z, JOHNSTON HE, et al. Small extracellular vesicles secreted from human amniotic fluid mesenchymal stromal cells possess cardioprotective and promigratory potential[J]. Basic Res Cardiol, 2020, 115(3): 26. DOI: 10.1007/s00395-020-0785-3.
|
[21] |
FEI X, CAI Y, LIN F, et al. Amniotic fluid mesenchymal stem cells repair mouse corneal cold injury by promoting mRNA N4-acetylcytidine modification and ETV4/JUN/CCND2 signal axis activation[J]. Hum Cell, 2021, 34(1): 86-98. DOI: 10.1007/s13577-020-00442-7.
|
[22] |
HAWKINS KE, CORCELLI M, DOWDING K, et al. Embryonic stem cell-derived mesenchymal stem cells (MSCs) have a superior neuroprotective capacity over fetal MSCs in the hypoxic-ischemic mouse brain[J]. Stem Cells Transl Med, 2018, 7(5): 439-449. DOI: 10.1002/sctm.17-0260.
|
[23] |
HUANG B, DING C, ZOU Q, et al. Human amniotic fluid mesenchymal stem cells improve ovarian function during physiological aging by resisting DNA damage[J]. Front Pharmacol, 2020, 11: 272. DOI: 10.3389/fphar.2020.00272.
|
[24] |
SHENDE P, SUBEDI M. Pathophysiology, mechanisms and applications of mesenchymal stem cells for the treatment of spinal cord injury[J]. Biomed Pharmacother, 2017, 91: 693-706. DOI: 10.1016/j.biopha.2017.04.126.
|
[25] |
KANGARI P, TALAEI-KHOZANI T, RAZEGHIAN-JAHROMI I, et al. Mesenchymal stem cells: amazing remedies for bone and cartilage defects[J]. Stem Cell Res Ther, 2020, 11(1): 492. DOI: 10.1186/s13287-020-02001-1.
|
[26] |
TRACY SA, AHMED A, TIGGES JC, et al. A comparison of clinically relevant sources of mesenchymal stem cell-derived exosomes: bone marrow and amniotic fluid[J]. J Pediatr Surg, 2019, 54(1): 86-90. DOI: 10.1016/j.jpedsurg.2018.10.020.
|
[27] |
DOMINICI M, LE BLANC K, MUELLER I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement[J]. Cytotherapy, 2006, 8(4): 315-317. DOI: 10.1080/14653240600855905.
|
[28] |
GALIPEAU J, SENSÉBÉ L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities[J]. Cell Stem Cell, 2018, 22(6): 824-833. DOI: 10.1016/j.stem.2018.05.004.
|